Zosano Pharma (ZSAN) Misses Q3 EPS by 11c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Zosano Pharma (ZSAN) Misses Q3 EPS by 11c

Zosano Pharma Reports Third Quarter 2015 Financial Results

November 9, 2015 4:01 PM EST

FREMONT, Calif., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ: ZSAN), a clinical-stage specialty pharmaceutical company, today announced financial results for the three months ended September 30, 2015.

We had a very eventful third quarter with updates on all programs. We are particularly pleased with our progress in building the depth and breadth of our organization and our clinical development advancements, said Vikram Lamba, Zosanos Chief Executive Officer. With the successful completion of our Phase 2 clinical trial on ZP-Glucagon with efficacy data demonstrating the patchs rapid onset of action and positive Phase 1 clinical trial data on... More